Italian Pharmaceuticals & Biotech Potentially Undervalued Companies

Sanofi

Market Cap: €96.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Regeneron Pharmaceuticals

Market Cap: €58.9b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Merck

Market Cap: €199.7b

Operates as a healthcare company worldwide.

Exact Sciences

Market Cap: €9.9b

Provides cancer screening and diagnostic test products in the United States and internationally.

Bayer

Market Cap: €27.1b

Operates as a life science company worldwide.

Jazz Pharmaceuticals

Market Cap: €7.8b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Thermo Fisher Scientific

Market Cap: €177.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Organon

Market Cap: €2.7b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

CureVac

Market Cap: €1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Johnson & Johnson

Market Cap: €425.3b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

BioMarin Pharmaceutical

Market Cap: €10.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Gerresheimer

Market Cap: €1.3b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Pfizer

Market Cap: €137.2b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Incyte

Market Cap: €16.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Zoetis

Market Cap: €63.2b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Bristol-Myers Squibb

Market Cap: €91.4b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Viatris

Market Cap: €11.2b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Merck KGaA

Market Cap: €47.0b

Operates as a science and technology company in Germany.

Biogen

Market Cap: €20.4b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Swedish Orphan Biovitrum

Market Cap: €96.3b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Qiagen

Market Cap: €9.9b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Iovance Biotherapeutics

Market Cap: €749.0m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Halozyme Therapeutics

Market Cap: €9.1b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Sarepta Therapeutics

Market Cap: €1.8b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Geron

Market Cap: €854.9m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Apellis Pharmaceuticals

Market Cap: €2.9b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Revvity

Market Cap: €9.9b

Provides health sciences solutions, technologies, and services.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €218.6m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Amgen

Market Cap: €154.4b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Novartis

Market Cap: €189.4b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Tecan Group

Market Cap: €2.0b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Revolution Medicines

Market Cap: €8.3b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Waters

Market Cap: €17.8b

Provides analytical workflow solutions in Asia, the Americas, and Europe.